Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00285_DB00503_nanopub.RAEbnQ4jUUu--FcXtvckzx7vWslfs8qXq8xK1N6GSx7eM#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00285_DB00503 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00285_DB00503 label "DDI between Venlafaxine and Ritonavir - Ritonavir, a CYP2D6 and CYP3A4 inhibitor, may decrease the metabolism and clearance of Venlafaxine, a CYP2D6 and CYP3A4 substrate. Monitor for changes in therapeutic/adverse effects of Venlafaxine if Ritonavir is initiated, discontinued, or dose changed. [drugbank_resource:DB00285_DB00503]" assertion.
- drugbank_resource:DB00285_DB00503 identifier "drugbank_resource:DB00285_DB00503" assertion.
- drugbank_resource:DB00285_DB00503 title "DDI between Venlafaxine and Ritonavir - Ritonavir, a CYP2D6 and CYP3A4 inhibitor, may decrease the metabolism and clearance of Venlafaxine, a CYP2D6 and CYP3A4 substrate. Monitor for changes in therapeutic/adverse effects of Venlafaxine if Ritonavir is initiated, discontinued, or dose changed." assertion.
- drugbank:DB00503 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00285_DB00503 assertion.
- drugbank:DB00285 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00285_DB00503 assertion.